Approval for prostate cancer treatment
Approval for atopic dermatitis treatment
FDA Breakthrough Therapy Designation for Glanzmann Thrombasthenia drug
New company targets dry eye disease with first-in-class therapy
EIC Accelerator: strong performance of engineering and tech-based companies
Ibex raises $55m to drive global adoption of AI for cancer diagnosis
Valhalla Ventures launches $66M fund to back deeptech innovators